Flash monitoring is a clinically effective method for achieving compensation for diabetes mellitus type 1
- Authors: Samoilova Y.G1, Koshmeleva M.V1, Oleynik O.A1, Filippova T.A1, Tolmachev I.V1, Kudlay D.A2,3, Mutalimi V.E1, Bolotova N.V4
-
Affiliations:
- Siberian State Medical University
- NRC Institute of Immunology FMBA of Russia
- I.M. Sechenov First Moscow State Medical University
- Saratov State Medical University named after V.I. Razumovsky
- Issue: Vol 18, No 5 (2020)
- Pages: 28-35
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113318
- DOI: https://doi.org/10.29296/24999490-2020-05-04
- ID: 113318
Cite item
Abstract
Full Text
About the authors
Y. G Samoilova
Siberian State Medical UniversityMoskovsky trakT., 2, Tomsk, 634050, Russian Federation
M. V Koshmeleva
Siberian State Medical UniversityMoskovsky trakT., 2, Tomsk, 634050, Russian Federation
O. A Oleynik
Siberian State Medical UniversityMoskovsky trakT., 2, Tomsk, 634050, Russian Federation
T. A Filippova
Siberian State Medical UniversityMoskovsky trakT., 2, Tomsk, 634050, Russian Federation
I. V Tolmachev
Siberian State Medical UniversityMoskovsky trakT., 2, Tomsk, 634050, Russian Federation
D. A Kudlay
NRC Institute of Immunology FMBA of Russia; I.M. Sechenov First Moscow State Medical UniversityKashirskoye highway, 24, Moscow, 115522, Russian Federation; Trubetskaya streeT., 8, bldg. 2, Moscow, 119991, Russian Federation
V. E Mutalimi
Siberian State Medical UniversityMoskovsky trakT., 2, Tomsk, 634050, Russian Federation
N. V Bolotova
Saratov State Medical University named after V.I. Razumovsky
Email: mvbulavko@mail.ru
Bolshaya Kazachia streeT., 112, Saratov, 410012, Russian Federation
References
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352 (9131): 837-53. https://doi.org/10.1016/S0140-6736(98)07019-6
- Nathan D.M., Cleary P.A., Backlund J.Y., Genuth S.M., Lachin J.M., Orchard T.J., Raskin P., Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 2005; 353 (25): 2643-53. https://doi.org/10.1056/NEJMoa052187
- Orchard T.J., Nathan D.M., Zinman B., Cleary P., Brillon D., Backlund J.Y., Lachin J.M. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015; (1): 45-53. https://doi.org/10.1001/jama.2014.16107.
- Самойлова Ю.Г, Ротканк М.А., Жукова Н.Г, Матвеева М.В., Толмачев И.В., Кудлай Д.А. Вариабельность гликемии у пациентов с сахарным диабетом 1-го типа: связь с когнитивной дисфункцией и данными магнитно-резонансных методов исследования. Проблемы Эндокринологии. 2018; 64 (5): 286-91.
- Алгоритмы специализированной медицинской помощи больным сахарным диабетом: клинические рекомендации. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. Сахарный диабет. 2017; 20 (1S, вып. 8): 1-121.
- Самойлова Ю.Г., Ротканк М.А., Жукова Н.Г., Матвеева М.В., Толмачев И.В., Кудлай Д.А. Маркеры когнитивных нарушений и вариабельность гликемии у пациентов с сахарным диабетом 1-го типа. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018; 118 (4): 48-51.
- Самойлова Ю.Г., Ротканк М.А., Жукова H. Г., Матвеева М.В., Толмачев И.В., Тонких O. С., Кудлай Д.А. Применение магнитнорезонансных методов исследования головного мозга у пациентов с сахарным диабетом 1-го типа и когнитивной дисфункцией. Неврологический журнал. 2018; 23 (2): 86-92.
- Davis W.A., Davis T.M. Cardiovascular risk prediction in adults with type 1 diabetes: the Fremantle Diabetes Study Diabetes Res. Clin. Pract. 2010; 90: 75-8.
- Dean J. Organising care for people with diabetes and renal disease. J. Ren. Care. 2012; 38 (1): 23-9.
- Eeg-Olofsson K., Cederholm J., Nilsson P.M. et al. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care. 2010; 33: 1640-6.
- American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2017; 40 (1): 1-135.
- Кошмелева М.В., Ю.Г Самойлова, О.С. Кобякова, Д.А. Кудлай, О.А. Олейник, М.В. Матвеева, Т.А. Филиппова, И.В Толмачев Опыт применения технологий дистанционного мониторинга сахарного диабета 1-го типа на этапе амбулаторного звена здравоохранения Педиатрия. 2019; 98 (5): 219-24.
- Raccah D., Sulmont V., Reznik Y. et al. In?cremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: The Real Trend study. Diabetes Care. 2009; 32 (12): 2245-50.
- Bolinder J., Antuna R., Geelhoed-Duijvestijn P. et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016; 388 (10057): 2254-63.
- Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial. Diabetes Care. 2010; 33: 17-22.
- Battelino T., Conget I., Olsen B. et al. SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012; 55: 3155-62.
- Riveline J.P., Schaepelynck P., Chaillous L. et al. EVADIAC Sensor Study Group. Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study Diabetes Care. 2012; 35: 965-71.
- Skyler J.S. Diabetic complications. The importance of glucose control. Endocrinol. Metab. Clin. North Am. 1996; 25 (2): 243-54.
- Ware J.E., Kosinski M., Keller S.D. SF-36 physical and mental health summary scales: a user's manual. New England Medical Center Hospital; Health Institute. 5-th print. Boston, 1994.
- Varni J., Seid M., Kurtin P. The PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med. Care. 2001; 39: 800-12.
- Никитина Т.П., Киштович А.В., Моисеенко Е.И. и др. Исследование качества жизни в педиатрии: разработка русской версии опросника PedsQL 4.0 Generic Core Scales для оценки качества жизни детей 8-12 лет. Вестник Межнационального центра исследования качества жизни. 2003; 1: 35-44.
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range, Tadej Battelino, Diabetes Care. 2019; 42 (8): 1593-603. https://doi.org/10.2337/dci19-0028
- Pickup J., Mattock M., Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomized controlled trials. BMJ. 2002; 324 (7339): 705.
- Шестакова М.В., Майоров А.Ю., Филиппов Ю.И. и др. Федеральные клинические рекомендации по помповой инсулинотерапии и непрерывному мониторированию гликемии у больных сахарным диабетом. Проект. Проблемы эндокринологии. 2015; 61 (6): 55-78.